Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:23 Feb 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1182.75 [ -2.05% ]TCS 2481.80 [ +2.92% ]

Sensex28892.97
28.26 0.10%

Nifty8939.50
12.60 0.14%

Midcap13532.11
25.18 0.19%

Smallcap13587.78
14.75 0.11%


Bse Corporate Announcements Back
Sun Pharma gets UK MHRA nod for Suveniz tablets product
Sun Pharma gets UK MHRA nod for Suveniz tablets product indicated for treatment of generalized anxiety disorder and cormobid indications in certain anxiety disorders with depression The UK Medicines and Healthcare products Regulatory Agency (UK MHRA) has granted Sun Pharmaceuticals a marketing authorization for the Sunveniz XL prolonged-release tablets in multiple strengths of 37.5 mg, 75 mg and 150 mg. It is indicative in treatment for generalized anxiety disorder, and comorbid indications in certain anxiety disorders with depression. Suvenzil tablets are marketed in UK by Pfizer under the brand name of Effexor. According Pfizer annual report 2009, It has annual global sales of US 548 million dollars.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com